UK Markets closed

Citrine Global Corp. (CTGL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0151-0.0043 (-22.16%)
At close: 12:14PM EDT

Citrine Global Corp.

2 4 Haogen Street
Herzliya 5250501
Israel
972 9 885 1422
https://www.citrine-global.com

Sector(s)Industrials
IndustrySpecialty Business Services
Full-time employees18

Key executives

NameTitlePayExercisedYear born
Ms. Ora Elharar SofferExec. Chairperson & CEO277.64kN/A1965
Ms. Ilanit Halperin CPACFO & Director111.45kN/A1971
Mr. Ilan Ben-IshayPartner & Director38.5kN/A1969
Tabe YdoChief Marketing OfficerN/AN/AN/A
Michel Vd BerghChief Commercial OfficerN/AN/AN/A
Mr. Laurence AlexanderEuropean Chief Exec. OfficerN/AN/AN/A
Ms. Osnat PhilippChief Exec. Officer of Novomic LtdN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company. It focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020. Citrine Global Corp. was incorporated in 2010 and is headquartered in Herzliya, Israel.

Corporate governance

Citrine Global Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.